CAADPE  California Association of Alcohol and Drug Program Executives, Inc.

Evidence has shown that the most effective treatment for people addicted to opioids is medication assisted therapy (MAT) combined with counseling services that address addiction and other behavioral issues. Burprenorphine, one such medication recently approved by the FDA, has shown to be a safer alternative to the traditional Methadone therapy.  

Therefore, CAADPE has recently partnered with Reckitt Benckiser Pharmaceuticals and the Alcohol and Drug Policy Institute (the Medication Assisted Therapy Education Project [MAT]) in an effort to seek answers and provide education where there is lack of understanding and collaboration in this area of treatment.  

Our goal for the project is to help AOD providers get ahead of the curve by understanding the current world of MAT and educating as to new options for treatment – in essence, to make as many treatment modalities available as possible and to promote access to these treatments. In order to best accomplish this, CAADPE is working on ways to strengthen relationships between AOD providers and physicians and providing avenues for educational resources.

Online Resources                                                                                                                                                                             There are resources available. Here are a few of them:

For information about where to find physicians approved to prescribe Burprenorphine and/or AOD treatment providers:

http://www.naabt.org/providers.cfm

National Alliance of Advocates for Buprenorphine Treatment (NAABT)

http://www.pcssmentor.org/

Physician Clinical Support System (PCSS)

For information about educational courses or curriculum:

http://www.attcnetwork.org/learn/education/dasp.asp

ATTC Network

http://www.csam-asam.org/TIP40.vp.html.

California Society of Addiction Medicine

http://www.attcnetwork.org/explore/priorityareas/science/blendinginitiative/buptx/product_materials.asp
http://bupawareness.nattc.org/explore/priorityareas/science/blendinginitiative/buptx/other_resources.asp

ATTC Training Materials from NIDA Blending Initiative

http://www.buppractice.com/

NIDA Site for MD's



For general policy information, drug information and frequently asked questions:

http://www.ncsl.org/default.aspx

National Council of State Legislatures

http://buprenorphine.samhsa.gov/

Substance Abuse & Mental Health Services Administration (SAMHSA)

Tip 40 and 43
View - http://www.kap.samhsa.gov/products/manuals/tips/index.htm#medicated
Download Tip 43 - http://download.ncadi.samhsa.gov/Prevline/pdfs/SMA08-4214.pdf
Download Tip 40 - http://ncadistore.samhsa.gov/catalog/productDetails.aspx?ProductID=16829

SAMHSA

http://www.suboxone.com/
http://www.heretohelpprogram.com/

Resources from Reckitt Benckhiser

http://www.pcssmentor.org/

New York Academy of Medicine

http://www.csam-asam.org/resources-buprenorphine_info.vp.html

CSAM Buprenorphine page


 

For news and announcements:

Campaign Launches to Sound Alarm about the Misuse of Prescription Drugs Among Teens

Substance Abuse & Mental Health Services Administration (SAMHSA)